Related references
Note: Only part of the references are listed.Normalization of adiponectin concentrations by leptin replacement in ob/ob mice is accompanied by reductions in systemic oxidative stress and inflammation
Gema Fruhbeck et al.
SCIENTIFIC REPORTS (2017)
Orchestrating high-throughput genomic analysis with Bioconductor
Wolfgang Huber et al.
NATURE METHODS (2015)
Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses
Ruijie Liu et al.
NUCLEIC ACIDS RESEARCH (2015)
Interleukin-6 deletion in mice driven by aP2-Cre-ERT2 prevents against high-fat diet-induced gain weight and adiposity in female mice
B. Navia et al.
ACTA PHYSIOLOGICA (2014)
Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior
Albert Quintana et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Lessons on Conditional Gene Targeting in Mouse Adipose Tissue
Kevin Y. Lee et al.
DIABETES (2013)
Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding
N. Turner et al.
DIABETOLOGIA (2013)
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
Helga Ellingsgaard et al.
NATURE MEDICINE (2011)
Human IL6 enhances leptin action in mice
M. Sadagurski et al.
DIABETOLOGIA (2010)
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
V. B. Matthews et al.
DIABETOLOGIA (2010)
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Guadalupe Sabio et al.
SCIENCE (2008)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes:: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness
AL Carey et al.
DIABETOLOGIA (2004)
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes
JJ Senn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
The cytochrome P450 superfamily: Biochemistry, evolution and drug metabolism in humans
PB Danielson
CURRENT DRUG METABOLISM (2002)
Interleukin-6-deficient mice develop mature-onset obesity
V Wallenius et al.
NATURE MEDICINE (2002)
Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion
B Vozarova et al.
OBESITY RESEARCH (2001)
Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-α levels after prolonged running
RL Starkie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Insulin signaling and insulin sensitivity after exercise in human skeletal muscle
JFP Wojtaszewski et al.
DIABETES (2000)
Share Paper
